# Rats Get the Munchies Too, According to New Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/rats-get-the-munchies-too-according-to-new-research/ > **Published:** 2026-06-25T12:18:32-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:50:35-04:00 > **Clinical Summary:** New preclinical research reveals how cannabis appetite stimulation works through shared neurobiological mechanisms in humans and animals. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCNeurologyMental HealthSafetyAnxietyPain Why This Matters This research identifies the neurobiological basis for cannabis-induced [appetite stimulation](https://cedclinic.com/dronabinol-hiv-wasting-syndrome-appetite-weight-gain/), which is clinically relevant for patients using cannabis therapeutically for conditions associated with poor appetite, such as cancer cachexia or HIV-related wasting. Clinicians prescribing or counseling patients about cannabis can now reference mechanistic evidence when discussing appetite effects, improving informed decision-making about whether this side effect represents a benefit or burden for individual patients. Understanding the shared biological mechanisms between animal models and humans strengthens the translational validity of preclinical findings, supporting more rigorous clinical trial design for appetite-related cannabis interventions. Clinical Summary [Cannabis-induced appetite stimulation](https://cedclinic.com/cannabis-based-appetite-therapies-pullman-study/), commonly known as “the munchies,” appears to operate through conserved biological mechanisms present in both rodents and humans, according to recent preclinical research. This finding strengthens the scientific basis for cannabinoid use in clinical contexts where [appetite stimulation](https://cedclinic.com/dronabinol-hiv-wasting-syndrome-appetite-weight-gain/) is therapeutically valuable, such as in cancer cachexia, HIV/AIDS-related wasting, and chemotherapy-induced anorexia. The identification of shared neurobiological pathways across species provides a more robust foundation for understanding how cannabis affects appetite regulation and may inform future development of targeted cannabinoid therapies with improved efficacy and reduced adverse effects. Understanding these fundamental mechanisms allows clinicians to better counsel patients about expected effects and to identify which patient populations might benefit most from appetite-stimulating cannabinoids. For clinicians considering cannabis for appetite-related indications, this research validates the clinical observations that [appetite stimulation](https://cedclinic.com/dronabinol-hiv-wasting-syndrome-appetite-weight-gain/) is a reliable and mechanistically sound therapeutic effect rather than merely a subjective side effect. Dr. Caplan’s Take “This rat study gives us early signals worth watching about the neurobiological pathways underlying [cannabis-induced appetite stimulation](https://cedclinic.com/cannabis-based-appetite-therapies-pullman-study/), but we need to see these mechanisms carefully replicated in human subjects before we can confidently apply them to clinical practice or patient counseling.” Clinical Perspective 🧠 This preclinical research reinforces the well-established clinical observation that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) is associated with increased appetite across mammalian species, likely mediated by [cannabinoid receptor signaling](https://cedclinic.com/cannabis-brain-volume-study-cognitive-benefits/) in hypothalamic feeding centers. While animal models provide valuable mechanistic insight into why patients report hunger increases during [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), translating these findings to clinical practice requires acknowledging important limitations: rodent studies use controlled doses and strains that may not reflect real-world human consumption patterns, genetic and environmental factors influence individual appetite responses, and the clinical relevance depends on whether increased appetite is therapeutically desired or problematic for a given patient. For healthcare providers managing patients who use cannabis, this research underscores that appetite stimulation is a predictable pharmacologic effect rather than merely subjective experience, which may be relevant when counseling patients about expected [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/) or when considering cannabis for appetite stimulation in conditions like cancer cachexia or HIV-related wasting. Clinicians 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Rats%20Get%20the%20Munchies%20Too%2C%20According%20to%20New%20Research%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D66696)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D66696)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Rats%20Get%20the%20Munchies%20Too%2C%20According%20to%20New%20Research%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D66696)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - ‘The munchies’ are real and could benefit those with no appetite – MSN - [From relationships to cannabis neuroscience: WWU’s podcast covers it – The Western Front](https://cedclinic.com/cannabis-neuroscience-harm-reduction-wwu-podcast/) - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) 📰 Source: [https://hightimes.com/study/rats-get-the-munchies-too-according-to-new-research/](https://hightimes.com/study/rats-get-the-munchies-too-according-to-new-research/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).